⚠️ Medical Disclaimer:GLP Metrics is an informational referral platform, not a medical provider. Content is not medical advice. Always consult a licensed doctor.Read Terms
GLP-1 / Weight Loss · United States

Semaglutide vs Tirzepatide:
The next generation of weight loss medications compared

A detailed breakdown for United States — including efficacy, cost, side effects, and how to get a prescription online.

Find Out Which Is Right for You →

Semaglutide vs Tirzepatide — At a Glance

💉

Semaglutide

GLP-1 agonist
Approved forT2D + Weight management
DoseUp to 2.4mg/week (inj.)
Avg result~15%
Est. cost$199–$349/mo (telehealth)
Insurance (CA)Often (T2D indication)
✓ Pros
✓Longer track record
✓More coverage options
✓Oral form (Rybelsus) available
✓Strong safety data
✗ Cons
✗Lower average weight loss than tirzepatide
✗Single receptor mechanism
🔬

Tirzepatide

GLP-1 + GIP dual agonist
Approved forT2D (Mounjaro) + Weight (Zepbound)
DoseUp to 15mg/week (inj.)
Avg result~20–22%
Est. cost$299–$399/mo (telehealth)
Insurance (CA)Limited in Canada
✓ Pros
✓Significantly higher weight loss
✓Dual mechanism targets two gut hormones
✓Impressive SURMOUNT trial results
✗ Cons
✗Newer — less long-term data
✗More expensive
✗Less insurance coverage currently
⚖️

Our Verdict

Tirzepatide achieves meaningfully higher weight loss (~20–22% vs ~15%) due to its dual GLP-1 + GIP mechanism. If maximum weight loss is the priority and cost/coverage is not a barrier, tirzepatide is the stronger option. Semaglutide remains excellent with a longer safety record and better coverage.

⚕️ This comparison is for informational purposes only. Consult a licensed physician before choosing any medication. Individual responses vary.

Find Your Best Option — Free Quiz →

Common Questions

Is tirzepatide better than semaglutide for weight loss?

Clinical data shows tirzepatide produces greater average weight loss (~20–22% vs ~15%). The SURMOUNT-1 trial demonstrated this superiority directly. However, individual responses vary significantly.

Is tirzepatide available in Canada?

Mounjaro (tirzepatide) received Health Canada approval for type 2 diabetes. It is available through some telehealth providers, though coverage remains limited compared to semaglutide.

What are the side effects of tirzepatide vs semaglutide?

Both share similar GI side effects (nausea, diarrhea, constipation). Tirzepatide's side effect profile is comparable based on clinical trial data, though it appears to be slightly better tolerated by some patients.

More Comparisons

Not Sure Which to Choose?

Take our free quiz and get a personalized recommendation from a licensed United States physician.

Start Free Quiz →